#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Conjunctivitis allergic Hepatic angiosarcoma Hyperchylomicronaemia Medulloblastoma Eosinophilic granulomatosis with polyangiitis Waldenstrom's macroglobulinaemia Intracranial calcification Systemic sclerosis pulmonary Rheumatoid arthritis Myelin oligodendrocyte glycoprotein antibody-associated disease Anti-neutrophil cytoplasmic antibody positive vasculitis Cutaneous T-cell lymphoma stage I Drug eruption Pulmonary alveolar haemorrhage Acute on chronic liver failure More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma recurrent – Diagnostics Vascular malformation – Treatment Alagille syndrome – Trials in Disease Erdheim-Chester disease Focal segmental glomerulosclerosis – Treatment Cholangitis sclerosing – Treatment Piriformis syndrome Osteosarcoma recurrent – Trials in Disease Wiskott-Aldrich syndrome Paraneoplastic neurological syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Binimetinib DROSPIRENONE L-Histidine Hydrochloride Threonine Clemastine Calcitriol Ly3484356 Amivantamab GT-002 Sacubitril Valsartan Xtmab-16 Ascorbic Acid Gallium (68Ga) 177Lu-Dpi-4452 Xaluritamig Ep0031 Ceftazidime Pentahydrate Evx-01 Misoprostol Abiraterone More therapies…

    Learn about Your Condition

    Inner ear disorder Pancreatic fistula Obesity Testicular germ cell tumour Glomerulonephritis membranous Metastasis Pancreatic carcinoma Herpes simplex meningitis Adenocarcinoma of colon Progressive multiple sclerosis Nephrolithiasis Laparotomy Hypersensitivity Urethral valves Affective disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic obstructive pulmonary disease

  • Study on Itepekimab for Former Smokers with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Itepekimab
    Bulgaria Czechia Estonia France Germany Hungary +6

  • Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tanimilast
    Austria Bulgaria Czechia Germany Greece Hungary +6

  • Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

    Not recruiting

    3 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Roflumilast
    • Tanimilast
    Austria Bulgaria Croatia Czechia Estonia Germany +8

  • Study on the Effects of Methylprednisolone and Placebo on Ventilator Support Duration in Severe COPD Patients in Intensive Care

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Methylprednisolone Hydrogen Succinate
    • Sodium Chloride
    France

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol in Patients Aged 40-80 with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Formoterol Fumarate Dihydrate
    • Salbutamol
    • Budesonide
    Bulgaria Hungary Poland

  • Study on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    2 1 1
    Belgium Bulgaria Czechia Denmark France Germany +5
Previous Page
1 … 5 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!